Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hyder

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Journal of Steroid Biochemistry|June 1, 1986
HPLC analysis of estrogen receptor by a multidimensional approachN A Shahabi, S M Hyder, R D Wiehle, et al.
Journal of Cardiothoracic and Vascular Anesthesia|January 4, 2001
Left ventricular assist device: hemodynamic profileN J Skubas, M Hyder, M Pasque, et al.
The American Journal of Dermatopathology|April 1, 1993
DNA determination in dysplastic nevi. A comparative study between flow cytometry and image analysisO P Sangueza, D M Hyder, A C Bakke, et al.
Hormones & Cancer|May 10, 2012
Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumorsBenford Mafuvadze, Yayun Liang, Cynthia Besch-Williford, et al.
The Journal of Biological Chemistry|April 14, 1995
The protooncogene c-jun contains an unusual estrogen-inducible enhancer within the coding sequenceS M Hyder, Z Nawaz, C Chiappetta, et al.
Journal of Chromatography|May 30, 1986
Interaction of estrogen receptor isoforms with immobilized monoclonal antibodiesN Sato, S M Hyder, L Chang, et al.
Journal of Chromatography|June 26, 1985
High-performance hydrophobic-interaction chromatography of steroid hormone receptorsS M Hyder, R D Wiehle, D W Brandt, et al.
American Journal of Hospital Pharmacy|October 1, 1984
Stability of theophylline in human serum and whole bloodC E Johnson, I A Cohen, S K Bickley, et al.
Nutrition and Cancer|October 17, 2013
Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer modelBenford Mafuvadze, Matthew Cook, Zhang Xu, et al.
International Journal of Oncology|November 6, 2012
The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor developmentCandace E Carroll, Yayun Liang, Indira Benakanakere, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Journal of Steroid Biochemistry|June 1, 1986
HPLC analysis of estrogen receptor by a multidimensional approachN A Shahabi, S M Hyder, R D Wiehle, et al.
Journal of Cardiothoracic and Vascular Anesthesia|January 4, 2001
Left ventricular assist device: hemodynamic profileN J Skubas, M Hyder, M Pasque, et al.
The American Journal of Dermatopathology|April 1, 1993
DNA determination in dysplastic nevi. A comparative study between flow cytometry and image analysisO P Sangueza, D M Hyder, A C Bakke, et al.
Hormones & Cancer|May 10, 2012
Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumorsBenford Mafuvadze, Yayun Liang, Cynthia Besch-Williford, et al.
The Journal of Biological Chemistry|April 14, 1995
The protooncogene c-jun contains an unusual estrogen-inducible enhancer within the coding sequenceS M Hyder, Z Nawaz, C Chiappetta, et al.
Journal of Chromatography|May 30, 1986
Interaction of estrogen receptor isoforms with immobilized monoclonal antibodiesN Sato, S M Hyder, L Chang, et al.
Journal of Chromatography|June 26, 1985
High-performance hydrophobic-interaction chromatography of steroid hormone receptorsS M Hyder, R D Wiehle, D W Brandt, et al.
American Journal of Hospital Pharmacy|October 1, 1984
Stability of theophylline in human serum and whole bloodC E Johnson, I A Cohen, S K Bickley, et al.
Nutrition and Cancer|October 17, 2013
Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer modelBenford Mafuvadze, Matthew Cook, Zhang Xu, et al.
International Journal of Oncology|November 6, 2012
The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor developmentCandace E Carroll, Yayun Liang, Indira Benakanakere, et al.
Pageof 13